Novel aqueous-phase redox flow batteries
Patent Information
- Application Number
- EP2023702440
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-01-27
- Filing Date
- 2023-01-27
- Publication Date
- 2024-12-04
AI Technical Summary
Aqueous phase flow redox batteries face challenges due to low solubility of anthraquinones in basic solutions, leading to electrode blockage, reduced performance, and high costs, as well as incompatibility of additives with ion exchange membranes, which affects energy efficiency and capacity.
Incorporating a solubilizing base with a pKa greater than 9.5 and specific organic or inorganic compounds in the negolyte, such as cesium or rubidium hydroxides, to enhance the solubility of anthraquinone-based electroactive molecules and ensure compatibility with the membrane and other electroactive molecules.
This approach significantly increases the solubility of anthraquinones, improves battery performance, and maintains compatibility with the ion exchange membrane, resulting in higher accessible capacity and energy efficiency at a lower industrial cost.
Smart Images

Figure 1.1
Abstract
Description
[0001] New aqueous-phase redox flow batteries
[0002] The present invention relates to the field of aqueous phase redox flow batteries. The present invention relates to a redox flow battery comprising a negolyte comprising one or more specific additives. The present invention also relates to a method for storing electricity by such a redox flow battery.
[0003] State of the art
[0004] A redox flow battery is a system that uses liquids (called electrolytes) to store energy. Redox flow batteries store electricity and release it through a redox reaction. They generally have two compartments, each containing the current collectors (electrodes), separated by an ion exchange membrane.
[0005] To date, several alternatives regarding the nature of the redox compounds (or electroactive molecules) in the electrolyte have been developed, including the use of organic, organometallic, coordination complex, or inorganic redox compounds. In particular, a number of compounds based on an anthraquinone nucleus have been used as electroactive molecules in aqueous electrolytes. However, the solubilities in basic aqueous phase (pH > 7) of some anthraquinones, especially those most readily available on the market and therefore with the most attractive prices, are not sufficiently high (anthraquinones typically have a solubility in aqueous phase much lower than 0.5 mol / L). Therefore, electrolytes comprising such anthraquinones are not economically competitive. Indeed, the solubility limit of anthraquinones induces the following problems:
[0006] - Blockage of the electrodes and / or the fluid circuit: i.e. depending on their state of charge, the solubility of the anthraquinones can decrease and lead to precipitation. The battery electrodes retain these precipitates in their porous structure, which increases the pressure losses experienced by the fluid and drastically reduces its flow rate in the cell, leading to a collapse in the battery's performance.
[0007] - Low system efficiency: low solubility available at any state of charge of the anthraquinone electroactive molecules leads to their use at low concentrations to avoid any problem of formation of solid species, which limits the amount of energy available in the battery. - Too high a system cost, because the limitation of the battery performance leads to an overall increase in costs. The lack of concentration of electroactive molecules must be compensated by increasing the volume of the reactors, and the reduction in accessible capacity must be compensated by increasing the quantity of electroactive molecules. In addition, the reduction in the concentration of the electrolyte reduces the usable nominal power density, which increases the cost per kW.
[0008] In WO2021 123334, it was shown by Kemiwatt that the use of electroactive molecules based on an anthraquinone core bearing certain water-solubilizing substituents makes it possible to increase their solubility, and therefore to obtain redox flow batteries with excellent performance. However, these molecules remain more expensive than some anthraquinones commercially available on an industrial scale.
[0009] Furthermore, the electrolytes of redox flow batteries may include, in addition to the electroactive molecules, one or more additives. In this case, it is necessary that the additive(s) be compatible with the ion exchange membrane of the battery, otherwise they may pollute the membrane, increase the resistance of the battery, and reduce its accessible capacity and energy efficiency. In addition, the additive(s) must be compatible with the electroactive molecules of each electrolyte (posolyte and negolyte). An incompatibility results, for example, in an interaction of the additive with the electroactive molecule, causing an increase in the viscosity of the fluid, a decrease in the diffusion coefficient of the charged and / or discharged species or a decrease in the rate constant of the electron transfer reaction, or simply a decrease in the solubility or a chemical degradation of the electroactive molecule.
[0010] Objectives of the invention
[0011] The present invention aims to solve the technical problem of providing an aqueous phase flow redox battery having high performance, particularly in terms of accessible capacity.
[0012] The present invention aims in particular to solve the technical problem of providing a redox flow battery whose electroactive molecule of the negolyte has a very high solubility in the aqueous phase.
[0013] The present invention aims in particular to solve the technical problem of providing a redox flow battery whose negolyte comprises an electroactive molecule based on an anthraquinone unit having a very high solubility in the aqueous phase, in particular in the case of electroactive molecules based on an anthraquinone unit which are easily accessible and inexpensive.
[0014] The present invention also aims to solve the technical problem of providing a redox flow battery whose negolyte and / or posolyte comprises at least one additive compatible with the ion exchange membrane and with the electroactive molecule(s) of the negolyte and, optionally, with that(s) of the posolyte, if necessary.
[0015] The complexity of these technical problems is notably linked to the fact of being able to resolve them all together, which is what the present invention proposes to do.
[0016] The present invention aims to solve all of these technical problems reliably and at an economically viable industrial cost.
[0017] Detailed description of the invention
[0018] The present invention makes it possible to solve one, and preferably all, of the technical problems posed by the present invention.
[0019] Thus, the present invention relates to a redox flow battery, comprising:
[0020] - a first compartment comprising a negolyte, in the form of an aqueous composition, comprising at least one compound of formula (I) [Chem 1] and / or a salt of the compound of formula (I), and / or a reduced form of the compound of formula (I), wherein X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 are independently selected from the group consisting of a hydrogen atom, a halogen, an ether group of formula -OA, an OH group, a COOH group, a -A-COOH group, a -OA-COOH group and, a linear, cyclic or branched, saturated or unsaturated hydrocarbon group, comprising from 1 to 10 carbon atoms, A representing a linear, cyclic or branched, saturated or unsaturated hydrocarbon group, comprising from 1 to 10 carbon atoms, in which at least one of X1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 includes an OH function, a COOH function or an A-COOH group,
[0021] - a second compartment comprising a posolyte, in the form of an aqueous composition, comprising at least one electroactive molecule, for example ferrocyanide ions [Fe(CN)6] 4 “ and / or ferricyanide ions [Fe(CN)6] 3 “, the negolyte further comprising at least one solubilizing base, the solubilizing base being characterized in that the pKa of the conjugate acid of the solubilizing base is greater than 9.5 in water at 25°C and in that the volume of the cation of the solubilizing base is between 14 and 650 cubic Angstroms.
[0022] By electroactive molecule is meant an organic or organometallic molecule forming part of an oxidation-reduction couple, and designates indifferently either the oxidant of the oxidation-reduction couple, or the reductant of the oxidation-reduction couple, or the mixture of the oxidant and the reductant of the oxidation-reduction couple, each of which can be in neutral form or in the form of an ion.
[0023] The electrolyte in the cathode compartment of the redox flow battery is called posolyte, and the electrolyte in the anode compartment of the redox flow battery is called negolyte.
[0024] Solubilizing base
[0025] The solubilizing base makes it possible to increase the solubility of the compound of formula (I), and in particular in its deprotonated form(s).
[0026] The solubilizing base is part of an acid / base pair. When the solubilizing base captures a proton, it becomes its conjugate acid.
[0027] The pKa of the conjugate acid of the solubilizing base corresponds to the -log (K a ), K a being the equilibrium constant of the dissociation reaction of the conjugate acid. The pKa of the conjugate acid of the solubilizing base is as described in the literature (General Analytical Chemistry Vol1 Aqueous and non-aqueous solutions. G. Chariot. Editions Masson (1967)) or as predicted by the COSMO-RS software (the details of the method are described in the article “Accurate prediction of basicity in aqueous solution with COSMO-RS”, F Eckert, A Klamt - Journal of computational chemistry, 2006 - Vol 27 Pages 11-19).
[0028] The solubilizing base can be in the form of a salt combining a cation and an anion, or in the form of a neutral molecule. In the case where the solubilizing base is in the form of a salt, the cation of the solubilizing base corresponds to the cation of the salt. In the case where the solubilizing base is in the form of a neutral molecule, the cation of the solubilizing base corresponds to the positively charged molecule obtained after protonation of the solubilizing base.
[0029] The volumes of the cations of the solubilizing bases are taken from the literature for alkali cations (Revised effective ionic radii in halides and chalcogenides” RD Shannon, Acta Crystallogr A (1976) 32, 751-767), or calculated with the COSMOtherm program for organic cations (method described in the book “From Quantum Chemistry to Fluid Phase thermodynamics and drug design”, Author: Andreas Klamt (2005), Publisher: Elsevier).
[0030] Preferably, the volume of the cation of the solubilizing base is between 14 and 420 cubic Angstroms, preferably between 14 and 250 cubic Angstroms.
[0031] Preferably, the solubilizing base is chosen from the group consisting of cesium or rubidium hydroxides, cesium or rubidium hydrogen carbonates, cesium or rubidium carbonates, and organic bases whose molar mass is between 58 and 400 grams per mole, the organic base not comprising an OH group in the terminal position.
[0032] An organic base is an organic compound that acts as a base. The organic base can be a neutral molecule or a salt, preferably a hydroxide, of an organic cation. An organic base consists of carbon and hydrogen atoms, nitrogen or phosphorus atoms, and possibly oxygen or sulfur atoms.
[0033] A terminal OH group is an OH group carried by a primary carbon atom, i.e. linked to a single other carbon atom, which corresponds to a primary alcohol function. For example, choline hydroxide is an organic base comprising a terminal OH group.
[0034] Preferably, the solubilizing base is not a halide salt, the halide being selected from F, Cl-, Br and I-.
[0035] Preferably, the solubilizing base is not a secondary amine. By secondary amine is meant a compound of formula NHRR', with R and R' being different from H. R and R' may be, for example, alkyl groups, linear or branched, optionally substituted and optionally comprising one or more unsaturations, or together form a hydrocarbon ring, optionally substituted, and optionally comprising one or more unsaturations.
[0036] Preferably, the solubilizing base is chosen from the group consisting of:
[0037] - caesium or rubidium hydroxides,
[0038] - caesium or rubidium hydrogen carbonates,
[0039] - caesium or rubidium carbonates,
[0040] - quaternary phosphonium hydroxides [RI R2R3R4P] + OH _ , in which R1, R2, R3 and R4 are independently chosen from the phenyl group, phenylalkyls -(CH2) n -Ph with n being an integer ranging from 1 to 5, and C1-C16, preferably C1-C6, linear, branched, or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position,
[0041] - quaternary ammonium hydroxides [RsReRyRsNJ+OH; in which either R5, Re, R7 and Rs are independently chosen from the phenyl group, phenylalkyls -(CH2) n-Ph with n being an integer ranging from 1 to 5, and C1-C16, preferably C1-C6, linear, branched or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, or R5 is chosen from C4-C20, preferably C8-C20, advantageously C12-C20, linear, branched or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, and Re, R7 and Rs, are independently chosen from C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Re, R7 and Rs are methyl groups, or R5 and Re are chosen from C4-C20 alkyl chains, preferably C8-C20, advantageously C12-C20,linear, branched or cyclic, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, and R7 and Rs, are independently chosen from C1-C3 alkyl chains, linear or branched, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously R7 and Rs are methyl groups, or Rs and Re form a saturated alkyl ring comprising from 4 to 6 carbon atoms, and R7 and Rs are chosen from C1-C6 alkyl chains, preferably C1-C3, linear or branched, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously R? and Rs are methyl groups, or R5, Rs and R? form an aromatic ring comprising 5 carbon atoms,and Rs is chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Rs is a methyl group,
[0042] - tertiary amines [R9R10R11N], in which either R9, R and Ru are independently chosen from C1-C8, preferably C1-C4, advantageously C1-C3, linear, branched or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, or Rg and R10 form a saturated alkyl ring comprising from 4 to 6 atoms, and Ru is chosen from C1-C8, preferably C1-C4, more preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Ru is an ethyl or methyl group,
[0043] - amidines [R a RbNC(Rc)=NR d ] in which either R a , Rb, Rc and R d, are independently chosen from C1-C8, preferably C1-C4, linear, branched, or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, i.e. R a and R d form a saturated alkyl ring comprising 2 to 4 carbon atoms, and Rb and R c form a saturated alkyl ring comprising from 3 to 5 carbon atoms, each ring being optionally substituted by a C1-C8, preferably C1-C4, advantageously C1-C3, linear or branched alkyl group, and
[0044] - guanidines [R e RfNC(NR g R h )=NH] in which R e, Rf, Rg and Rh, are independently chosen from C1-C8, preferably C1-C4, linear, branched, or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position. According to one embodiment, R1, R2, R3 and R4 are identical.
[0045] According to one embodiment, the quaternary phosphonium hydroxide is tetrabutyl phosphonium hydroxide.
[0046] According to one embodiment, the quaternary ammonium hydroxides [RsReRyRsNJ+OH are such that:
[0047] - either R5, Re, R? and Rs are chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously R5, Re, R7 and Rs are methyl groups,
[0048] - either R5, Re and R? are chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, and Rs is chosen from the phenyl group, phenylalkyls -(CH2)n-Ph with n being an integer ranging from 1 to 5, and C8-C20 alkyl chains,
[0049] - either R5 is chosen from linear C4-C20, preferably C8-C20, advantageously C12-C20 alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, and Re, R7 and Rs are independently chosen from linear C1-C3 alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Re, R7 and Rs are methyl groups,
[0050] - either R5 and Re form a saturated alkyl ring comprising from 4 to 6 carbon atoms, and R7 and Rs are chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously R7 and Rs are methyl groups,
[0051] - either R5, Re and R7 form an aromatic cycle comprising 5 carbon atoms, and Rs is chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Rs is a methyl group.
[0052] According to one embodiment, R5, Re, R7 and Rs are independently chosen from the phenyl group, the phenylalkyls -(CH2) n-Ph with n being an integer ranging from 1 to 5, preferably n = 1, and C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position.
[0053] According to one embodiment, either Rs, Re, R? and Rs are identical and chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, preferably linear, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, or Rs is chosen from phenylalkyls -(CH2)n-Ph with n being an integer ranging from 1 to 5, preferably n = 1, and Re, R? and Rs are independently chosen from C1-C6, preferably C1-C3, linear or branched alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously and Re, R? and Rs are methyl groups.
[0054] According to one embodiment, the quaternary ammonium hydroxides [RsReRyRsNJ+OH are selected from the group consisting of tetramethylammonium hydroxide, tetraethylammonium hydroxide, tetrapropylammonium hydroxide, tetrabutylammonium hydroxide, trimethylbenzylammonium hydroxide, trimethylcetylammonium hydroxide, dimethyldidocecylammonium hydroxide, trimethylphenylammonium hydroxide, N-methylpyridinium hydroxide, dimethylpyrrolidinium hydroxide and dimethylpiperidinium hydroxide.
[0055] According to one embodiment, R5, Re, R? and Rs are identical and chosen from C1-C6, preferably C1-C3, linear or branched, preferably linear, alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously R5, RS, R? and Rs are methyl groups.
[0056] Preferably, the quaternary ammonium hydroxide [RsReRyRsNJ+OH- is tetramethylammonium hydroxide or trimethylbenzylammonium hydroxide.
[0057] According to one embodiment, the tertiary amines [R9R10R11N] are such that
[0058] - either R9, R10 and R11 are identical and chosen from C1-C8, preferably C1-C4, advantageously C1-C3, linear or branched, preferably linear, alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position,
[0059] - either R and R10 form a saturated alkyl ring comprising from 4 to 6 atoms, and Ru is chosen from C1-C8 alkyl chains, linear or branched, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Ru is an ethyl or methyl group.
[0060] According to one embodiment, the tertiary amines [R9R10R11N] are selected from the group consisting of trimethylamine, triethylamine, ethyldimethylamine, methyldiethylamine, N-methylpyrrolidine, N-ethylpyrrolidine, N-methylpiperidine and N-ethylpiperidine. Preferably, the tertiary amines [R9R10R11N] are selected from the group consisting of trimethylamine, triethylamine and N-methylpyrrolidine.
[0061] According to one embodiment, the amidines [R a RbNC(Rc)=NR d ] are such that R a and Rd form a saturated alkyl ring comprising from 2 to 4 carbon atoms, and Rb and R c form a saturated alkyl ring comprising from 3 to 5 carbon atoms, each ring being optionally substituted by a C1-C8, preferably C1-C4, advantageously C1-C3, linear or branched alkyl group.
[0062] According to one embodiment, amidine [R a RbNC(R c )=NRd] is 1,8-diazabicyclo[5.4.0]undec-7-ene.
[0063] According to one embodiment, R e , Rf, R g and Rh, are identical.
[0064] According to one embodiment, guanidine [R e RfNC(NR g R h )=NH] is 1,1,3,3-tetramethylguanidine.
[0065] The different embodiments concerning the nature of the different families of solubilizing base (caesium or rubidium hydroxides, caesium or rubidium hydrogen carbonates, caesium or rubidium carbonates, quaternary phosphonium hydroxides [RI R2RSR4P] + OH', quaternary ammonium hydroxides [RsReRyRsNJ+OH; tertiary amines [R9R10R11N], amidines [R a RbNC(R c )=NR d ] and guanidines [R e RfNC(NR g R h )=NH]) are independent and combinable with each other.
[0066] Preferably, the solubilizing base is selected from the group consisting of CsOH, RbOH, trimethylamine, triethylamine, ethyldimethylamine, methyldiethylamine, N-methylpyrrolidine, N-ethylpyrrolidine, N-methylpiperidine, N-ethylpiperidine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,1,3,3-tetramethylguanidine, tetramethylammonium hydroxide, tetraethylammonium hydroxide, tetrapropylammonium hydroxide, tetrabutylammonium hydroxide, trimethylbenzylammonium hydroxide, trimethylcetylammonium hydroxide, dimethyldidocecylammonium hydroxide, trimethylphenylammonium hydroxide, N-methylpyridinium hydroxide, N,N-dimethylpyrrolidinium hydroxide, N,N-dimethylpiperidinium hydroxide and tetrabutylphosphonium hydroxide.
[0067] Preferably, the solubilizing base is selected from the group consisting of CsOH, RbOH, trimethylamine, triethylamine, N-methylpyrrolidine, 1,1,3,3-tetramethylguanidine, tetramethylammonium hydroxide, tetrabutylammonium hydroxide, trimethylbenzylammonium hydroxide and tetrabutylphosphonium hydroxide.
[0068] Neqolyte
[0069] The negolyte of the redox flow battery according to the invention comprises at least one solubilizing base.
[0070] Preferably, the solubilizing base has a molar concentration in the negolyte of between 0.1 mol / L and 5.0 mol / L, preferably between 0.2 mol / L and 4.0 mol / L, preferably between 0.3 mol / L and 3.0 mol / L, advantageously between 0.4 mol / L and 2.5 mol / L.
[0071] When the negolyte comprises several solubilizing bases (at least two), the total molar concentration of all the solubilizing bases is between 0.1 mol / L and 5.0 mol / L, preferably between 0.2 mol / L and 4.0 mol / L, preferably between 0.3 mol / L and 3.0 mol / L, advantageously between 0.4 mol / L and 2.5 mol / L.
[0072] According to one embodiment, the negolyte is free of Cl' ion and Br ion, preferably is free of halide ion, the halide ion being chosen from F', Cl', Br and I'. According to one embodiment, the negolyte further comprises a secondary base chosen from potassium hydroxide, sodium hydroxide, lithium hydroxide, ammonium hydroxide, preferably from potassium hydroxide, sodium hydroxide and lithium hydroxide.
[0073] The cation of the secondary base is therefore a cation chosen from K + , N / A + , Li + and NH4 + , preferably among K +, N / A + and Li + .
[0074] The role of the secondary base is to increase the conductivity as well as the pH of the negolyte, in addition, it allows to provide cations which diffuse through the membrane at a speed suitable for the application.
[0075] The secondary base according to the invention does not comprise a divalent cation, such as Mg 2+ . The presence of a divalent cation may decrease the solubility of the compound of formula (I) in the negolyte. Preferably, the secondary base has a molar concentration in the negolyte of between 0.01 mol / L and 5.0 mol / L, preferably between 0.2 mol / L and 4.0 mol / L, preferably between 0.3 mol / L and 3.0 mol / L, advantageously between 0.4 mol / L and 2.5 mol / L.
[0076] In the negolyte, [M so iub,nego] corresponds to the molar concentration in the negolyte in cation of the solubilizing base as defined according to the invention, and [M Second,nego] corresponds to the molar concentration in the negolyte of the secondary base cation. Preferably, the ratio between [M so iub,nego] and [M'second.nego] is greater than or equal to 0.1, preferably greater than or equal to 0.3, more preferably greater than or equal to 0.6 and less than or equal to 10, advantageously greater than or equal to 0.8 and less than or equal to 3.
[0077] This helps improve the applicability of the battery, especially when used in real conditions.
[0078] The negolyte of the redox flow battery according to the invention further comprises at least one compound of formula (I).
[0079] Preferably, the molar concentration of the compound of formula (I) in the negolyte is between 0.1 mol / L and 2 mol / L, preferably between 0.2 mol / L and 1.0 mol / L, preferably between 0.25 mol / L and 0.8 mol / L, advantageously between 0.3 mol / L and 0.6 mol / L.
[0080] Halogen means the atoms F, Cl, Br and I.
[0081] According to one embodiment, the redox flow battery according to the invention may comprise a mixture of at least two compounds of formula (I) different from each other.
[0082] Preferably, X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8are independently selected from the group consisting of a hydrogen atom, a halogen, an ether group of formula -OA, an OH group, a COOH group, a -A-COOH group, a -OA-COOH group and, a linear or branched, saturated hydrocarbon group comprising from 1 to 10 carbon atoms, preferably from 1 to 8 carbon atoms, more preferably from 1 to 6 carbon atoms, advantageously from 1 to 4 carbon atoms, and A representing a linear or branched, saturated hydrocarbon group comprising from 1 to 10 carbon atoms, preferably from 1 to 8 carbon atoms, more preferably from 1 to 6 carbon atoms, advantageously from 1 to 4 carbon atoms.
[0083] According to one embodiment, X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8of the compound of formula (I) are independently selected from the group consisting of a hydrogen atom, an OH group, a COOH group, a (CH2) group n -COOH where n is an integer ranging from 1 to 10 and a linear, cyclic or branched, saturated or unsaturated hydrocarbon group, comprising from 1 to 10 carbon atoms.
[0084] Preferably, the compound of formula (I) is selected from the group consisting of: [Chem 2]
[0085] Preferably, the compound of formula (I) is selected from the group consisting of quinizarin (1,4-DHAQ), chrysazine (1,8-DHAQ), anthrarufin (1,5-DHAQ), alizarin (1,2-DHAQ), anthraflavic acid (2,6-DHAQ) and cassic acid (1,8-DHAQ-3-COOH).
[0086] According to another embodiment, in the compound of formula (I) according to the invention, X 3 = H, one and only one among X 1 , X 2 , X 4 , X 5 , X6 , X 7 and X 8 represents OH, and one and only one of X 1 , X 2 , X 4 , X 5 , X 6 , X 7 and X 8 represents -OA-COOH.
[0087] Preferably, A represents (CH2)n, optionally substituted, where n is an integer chosen from 1 to 10, preferably chosen from 2 to 5 and more preferably equal to 3 or 4.
[0088] Preferably, in the compound of formula (I) according to the invention,
[0089] X 1 = -OA-COOH and X 2 = OH, or
[0090] X 1 = OH and X 2 = -OA-COOH, or
[0091] X 1 = -OA-COOH and X 4 = OH, or
[0092] X 1 = -OA-COOH and X 5 = OH, or
[0093] X 2 = -OA-COOH and X 6 = OH, or
[0094] X 2 = -OA-COOH and X 7 = OH, or
[0095] X 1 = -OA-COOH and X 8 = OH.
[0096] Preferably, in the compound of formula (I) according to the invention, X 1 , X 2 , X 4 , X 5 , X 6 , X 7 and X 8 are independently selected from the group consisting of a hydrogen atom, an OH group and a -OA-COOH group, in which one and only one of X 1 , X 2 , X 4 , X 5 , X 6 , X 7 and X 8 is OH, and in which one and only one of X 1 , X 2 , X 4 , X 5 , X 6 , X 7 and X 8 is -OA-COOH.
[0097] Preferably, in the compound of formula (I) according to the invention, X 1 = OH and X 4 = - OA-COOH, preferably X 1 = OH and X 4 = -O-(CH2)3-COOH. Even more preferably, X 1 = OH, X 4 = -OAR 1 and X 2 = X5 = X 6 = X 7 = X 8 = H. Advantageously, X 1 = OH, X 4 = -O-(CH2)3-COOH and X 2 = X 5 = X 6 = X 7 = X 8 = H. According to one embodiment, the neolytic consists of one or more solubilizing bases, one or more of formula (I), and optionally one or more secondary bases as defined in the present invention. All the embodiments and preferred characteristics defined above for the neolytic apply.
[0098] Posolve
[0099] The posolyte comprises at least one electroactive molecule.
[0100] Preferably, the molar concentration of the electroactive molecule in the posolyte is between 0.1 mol / L and 4 mol / L, preferably between 0.4 mol / L and 2 mol / L, preferably between 0.5 mol / L and 1.6 mol / L, advantageously between 0.6 mol / L and 1.2 mol / L.
[0101] Among the electroactive molecules, mention may be made of the ferrocyanide ion and / or the ferricyanide ion, ferrocene and / or ferrocenium ions, the ferrocene and the ferrocenium ion being optionally substituted by at least one -A-Zi group or one -OA-Z1 group, A representing a linear, cyclic or branched, saturated or unsaturated hydrocarbon group, comprising from 1 to 10 carbon atoms and Z1 being -CO2H, -PO3H; -PO4H; -SO3H or -SO4.
[0102] Preferably, the electroactive molecule of the posolyte is the ferrocyanide ion and / or the ferricyanide ion. The ferrocyanide ion is introduced into the posolyte in the form of a salt, preferably a potassium, lithium, sodium or ammonium salt, advantageously in the form of a potassium salt.
[0103] The posolyte may further comprise at least one base chosen from solubilizing bases and secondary bases as defined in the present invention.
[0104] Preferably, the base has a molar concentration in the posolyte of between 0.01 mol / L and 1.00 mol / L, preferably between 0.01 mol / L and 0.60 mol / L, preferably between 0.01 mol / L and 0.40 mol / L, advantageously between 0.01 mol / L and 0.20 mol / L.
[0105] According to one embodiment, the base included in the posolyte is chosen from solubilizing bases as defined in the part of the description above relating to the solubilizing base. Preferably, the solubilizing base is in the form of a salt, preferably a hydroxide salt. The solubilizing base is therefore preferably formed from an MB cation and an anion, preferably an MB cation and a hydroxide anion, the MB cation being chosen from the group consisting of Cs + , Rb + , quaternary phosphoniums [RI R2R3R4P] +and quaternary ammoniums [RsReRyRsNjL Ri, R2, R3, R4, R5, Re, R? and Rs being as defined above. In this embodiment, it may be advantageous for the electroactive molecule of the posolyte to be an anion, and therefore to be introduced in the form of a salt whose MME cation is chosen from the group consisting of Cs + , Rb + , quaternary phosphoniums [RI R2R3R4P] + and quaternary ammoniums [R5R6R7R8N] + , RI, R2, R3, R4, Rs, Re, R7 and Rs being as defined above. According to an advantageous embodiment, the cation ME of the electroactive molecule and the cation M B of the solubilizing base are identical. Thus, according to this embodiment, the posolyte comprises M cations, which represent the set of MB and MME cations. According to this embodiment, the posolyte is preferably devoid of secondary base. According to this embodiment, the posolyte is preferably devoid of K cation + , N / A+ , Li + and NH4 + .
[0106] Preferably, the molar concentration of cations M in the posolyte is between 0.1 mol / L and 17 mol / L, preferably between 0.4 mol / L and 8.6 mol / L, preferably between 0.5 mol / L and 6.8 mol / L, advantageously between 0.6 mol / L and 5 mol / L, the cations M being chosen from the group consisting of Cs + , Rb + , quaternary phosphoniums [RI R2R3R4P] + and quaternary ammoniums [R5R6R7R8N] + , Ri, R2, R3, R4, Rs, Re, R7 and Rs being as defined above.
[0107] According to another embodiment, the base included in the posolyte is chosen from secondary bases as defined above. The base included in the posolyte is therefore preferably of formula MB'OH, with MB' being chosen from the group consisting of K + , N / A + , Li + and NH4 +. In this embodiment, the electroactive molecule may optionally be introduced in the form of a salt, the cation MME' of which is chosen from the group consisting of K + , N / A + , Li + and NH4 + . Thus, according to this embodiment, the posolyte comprises M' cations, which represent either the MB' cations or the set of MB' and MME' cations.
[0108] Preferably, the molar concentration of cations M' is between 0.1 mol / L and 17 mol / L, preferably between 0.4 mol / L and 8.6 mol / L, preferably between 0.5 mol / L and 6.8 mol / L, advantageously between 0.6 mol / L and 5 mol / L, the cations M' being chosen from the group consisting of K + , N / A + , Li + and NH4 + .
[0109] According to this embodiment, the posolyte may further comprise at least one solubilizing base as defined throughout the description above. In this case, the molar concentration of solubilizing base is between 0.01 mol / L and 1 mol / L, preferably between 0.01 mol / L and 0.6 mol / L, preferably between 0.01 mol / L and 0.4 mol / L, advantageously between 0.01 mol / L and 0.2 mol / L. According to one embodiment, the posolyte is free of Cl' ion and Br ion, preferably is free of halide ion, the halide ion being chosen from F', Cl', Br and I'
[0110] According to another embodiment, the negolyte and the posolyte are free of Cl' ion and Br ion, preferably are free of halide ion, the halide ion being chosen from F', Cl', Br and I'.
[0111] According to one embodiment, the posolyte consists of one or more electroactive molecules and one or bases chosen from solubilizing bases and secondary bases. All the embodiments and preferred characteristics defined above for the posolyte apply.
[0112] Battery
[0113] The redox flow battery according to the invention further comprises a membrane, preferably an amphoteric membrane or a semi-permeable cation exchange membrane, said membrane comprising a material selected from the group consisting of fluorinated (co)polymers, (co)poly(ether ketone), (co)poly(ether sulfone), (co)poly(ether-ether-ketone), sulfonated (co)poly(ether-ether-ketone), benzimidazole (co)polymers and arylene-based (co)polymers, preferably selected from the group consisting of fluorinated copolymers based on sulfonated tetrafluoroethylene, perfluorosulfonic acid ionomers, and sulfonated (co)poly(ether-ether-ketone).
[0114] Preferably, the posolyte and the negolyte have a temperature between 10°C and 50°C, preferably between 15°C and 45°C, advantageously between 20°C and 40°C.
[0115] According to the invention, the battery comprises a molar quantity n so iub,batt in cation of the solubilizing base M SOiU b,batt, and possibly a molar quantity n' se cond,batt in cation chosen from the group consisting of K + , N / A + , Li + and NH4 + . The molar quantity n so iub,batt corresponds to the molar quantity of cation of the solubilizing base in the negolyte, to which is possibly added the molar quantity of cation of the solubilizing base in the posolyte. The molar quantity n' se cond,batt corresponds, when present, to the molar quantity of cation chosen from the group consisting of K + , N / A + , Li + and NH4 +in the negolyte, or to the molar quantity of cation chosen from the group consisting of K + , N / A + , Li + and NH4 + in the posolyte, or to the sum of the molar quantity of cation chosen from the group consisting of K + , N / A + , Li + and NH4 + in the negolyte and the posolyte. Preferably, the ratio between n so iub,batt and n' se cond,batt is greater than or equal to 0.1, preferably greater than or equal to 0.3, more preferably greater than or equal to 0.6 and less than or equal to 10, advantageously greater than or equal to 0.8 and less than or equal to 3.
[0116] The present invention also relates to a method for storing electricity by at least one redox flow battery, characterized in that the redox flow battery is according to the invention.
[0117] The present invention also relates to a method for producing electricity by at least one redox flow battery, characterized in that the redox flow battery is according to the invention.
[0118] Description of figures
[0119] [Fig 1] Figure 1 is a voltammogram of alizarin (5 x 1O -3 M) in 0.1 M KOH (in black) and 0.1 M CsOH (in gray). Scanning speed 20 mV.s -1 .
[0120] [Fig 2] Figure 2 is a graph showing the evolution of the discharge capacity of battery No. 1 over the course of the charge and discharge cycles (first 50 cycles shown).
[0121] [Fig 3], [Fig 4] Figures 3 and 4 are graphs showing the evolution of the discharge capacity of battery No. 2 as the charge and discharge cycles progress (first 27 cycles shown, and cycles 296 to 328 shown, respectively).
[0122] [Fig 5]Figure 5 is a graph showing the evolution of the discharge capacity of battery No. 3 over the course of the charge and discharge cycles (first 120 cycles shown).
[0123] [Fig 6] Figure 6 is a graph showing the evolution of the discharge capacity of battery No. 4 over the course of the charge and discharge cycles (first 10 cycles shown).
[0124] [Fig 7] Figure 7 is a graph showing the evolution of the energy density of batteries No. 3 (black curve) and No. 4 (grey curve) as the charge and discharge cycles progress (first 10 cycles shown).
[0125] [Fig 8] Figure 8 is a graph representing the evolution of the solubility of a compound of formula (I) according to the invention (alizarin) as a function of the molar ratio between the molar concentration of solubilizing base on the sum of the molar concentration of solubilizing base and the molar concentration of secondary base (equilibrated for 1 day at 21°C).
[0126] [Fig 9] Figure 9 is a graph representing the evolution of the solubility of a compound of formula (I) according to the invention (quinizarin) as a function of the molar ratio between the molar concentration of solubilizing base on the sum of the molar concentration of solubilizing base and the molar concentration of secondary base (equilibrated for 3 days at 21°C).
[0127] The present invention will now be described with the aid of non-limiting examples.
[0128] Examples
[0129] Example 1: Characteristics of solubilizing bases according to the invention and of secondary bases
[0130] Table 1 below presents the characteristics of different examples of solubilizing bases according to the invention, and of secondary bases LiOH, NaOH, KOH and NH4OH (different from the solubilizing bases). In particular, the pKa of the corresponding conjugate acid of each base and the volume of the corresponding cation of each base are reported.
[0131] [Table 1] a: “Correlation of the Base Strengths of Amines” HK Hall, J. Amer. Chem. Soc (1957) 79, 5441 b: These ionic radii correspond to the hexa-coordinated cations within a crystal. “Revised effective ionic radii in halides and chalcogenides” RD Shannon, Acta Crystallogr A (1976) 32, 751-767 c: “On the effective ionic radii for ammonium” V. Sidey, Acta Crystallogr B (2016) B72, 626 d: The volumes of the organic cations are calculated with the COSMOtherm 2021 software and their radii are calculated from the volumes by assimilating the cation to a sphere.
[0132] Example 2: Enhancement of the solubility of compounds of formula (I) by the presence of a solubilizing base according to the invention
[0133] The solubility of some compounds of formula (I) in water was evaluated in the presence of 1.2 mol / L of different solubilizing bases alone or in the presence of LiOH, NaOH, KOH and possibly NH4OH (secondary base). More precisely, it is a question of evaluating the solubility of the ion pair, [deprotonated anthraquinone-cation], resulting from the deprotonation of the compounds of formula (I) by said bases. The table below indicates the relative solubility of these compounds of formula (I) compared to a reference solubility which is their solubility in the presence of 1 mol / L of NaOH.
[0134] [Table 2]
[0135] Completely unexpectedly, the presence of a solubilizing base in an aqueous solution of different compounds of formula (I) makes it possible to dramatically increase (up to 4000 times) the solubility of these compounds of formula (I).
[0136] Example 3: Comparison of the solubility in water of compounds of formula (I) in negolytes of different compositions
[0137] The table below shows the relative solubility of quinizarin and chrysazine as a function of different negolyte compositions, the relative solubility being in relation to a reference solubility which is their solubility in the presence of 1.1 mol / L of KOH. The absolute solubilities of quinizarin and chrysazine in a 1 mol / L aqueous KOH solution are respectively equal to 3.1 x10 -2 mol / L and 4.8x10 -3 mol / L.
[0138] The negolytes comprising NMe4OH (a solubilizing base according to the invention) and KOH are according to the invention, and the negolytes comprising only KOH or tetramethylammonium chloride are comparative (tetramethylammonium chloride is not a solubilizing base according to the invention. Indeed, tetraalkylammonium halides are not bases or acids, and therefore do not have a pKa. When dissolved, they do not modify the pH, whatever the quantity introduced).
[0139] [Table 3]
[0140] In the presence of tetramethylammonium chloride, quinizarin and chrysazine remain very slightly soluble in aqueous medium. Only the presence of one or more solubilizing base(s) according to the invention makes it possible to significantly improve the solubility of these two compounds in aqueous medium.
[0141] Example 4 (comparative): Solubility in water of compounds other than the compounds of formula (I) according to the invention The following table shows the relative solubilities in water of anthraquinone-
[0142] SO3H following which is not a compound of formula (I) according to the invention.
[0143] [Chem 3]
[0144] [Table 4]
[0145] These results demonstrate that whatever the base used, even a solubilizing base according to the invention, the acid form of a sulfonated anthraquinone is more soluble than the deprotonated form, unlike the compounds of formula (I) according to the invention whose protonated carboxylic (R-CO2H) and phenolic (Ar-OH) forms are very slightly soluble in water, whereas the forms deprotonated by a solubilizing base according to the invention are more soluble. Indeed, the above AQ-SOsH is a strong acid whose ion pair is particularly dissociated compared to that of the anthraquinones substituted by an OH group and / or by a COOH group.
[0146] Example 5: Study of the compatibility of solubilizing bases with different membranes
[0147] The influence of the presence of a solubilizing base in the negolyte on the performance of two membranes was evaluated by studying the ohmic resistance of a symmetrical cell, according to the protocol described below.
[0148] An electrolyte comprising a 50:50 mixture of sodium ferricyanide and sodium ferrocyanide at a total concentration of 0.5 mol / L is formulated. This electrolyte is introduced into the two compartments of a redox flow battery whose cell is composed of the membrane to be tested. The membranes tested are two semi-permeable cation exchange membranes with two different structures: i) the first is composed of a perfluorinated skeleton and a perfluorosulfonated chain to ensure its ionic conduction (Nation type, Solvay grade 50 pm,K+); ii) the second is composed of a sulfonated poly(ether-ether-ketone) skeleton (hydrocarbon type, Fumatech Fumasep E620K grade).
[0149] The battery, called symmetrical since it is composed of two electrolytes of identical formulation, is in a state of charge imposed by the proportion of the ferricyanide (charged form) / ferrocyanide (discharged form) mixture, i.e. 50%. This state of charge allows the measurement of the strictly ohmic resistance of the cell, thus obscuring the polarization contributions i) of charge transfer activation and ii) of material transport which appear respectively at the beginning and end of the charging and discharging processes of a battery cycle.
[0150] A linear polarization curve (LPC) is programmed as a current ramp and the cell resistance value is deduced by measuring the slope obtained by plotting j = f(U); J being the current density (mA / cm 2) imposed on the cell, U being the measured voltage (V) across the cell terminals. This value is confirmed after reversible cycling of 5 cycles at a current of ±2A whose capacity is limited to 20 mA.h (i.e. 15% of SOC) and the drawing of a new CPL. This experimental loop is repeated until the value of the active surface resistance (ASR) of the cell is stable and therefore reliable.
[0151] 0.1 mol / L of the solubilizing base to be studied is dissolved in each compartment of the battery (same final pH), and the previous protocol is repeated in order to establish the resistance value corrected by the presence of the introduced species. This cell active surface resistance value is compared to that of the reference, namely that obtained with 0.1 mol / L of NaOH.
[0152] The results obtained are shown in the table below. The word "Compatible" means that the active cell surface resistance measured with the compound in question is comparable to that obtained with 0.1 mol / L of NaOH to within 5%. The word "Incompatible" means that the latter exceeds the reference value by more than 5%; in this case, this value is reported.
[0153] [Table 5]
[0154] These results highlight that the compatibility between cations and the membrane depends on the nature of the skeleton making up this membrane.
[0155] Example 6: Study of the chemical compatibility of solubilizing bases with the posolyte
[0156] Ferricyanide, the oxidized form of ferrocyanide, is formed in the battery's posolyte as soon as the state of charge (SOC) is greater than 0%. At 100% SOC, the posolyte consists solely of ferricyanide. Under these conditions, the electrolyte acquires an oxidizing character.
[0157] When adding an additive to a battery, such as a solubilizing base, it is important to check whether it is compatible with all the battery elements, and in particular its resistance to oxidation in the event of contact with ferricyanide. This is relevant even if the additive is added to the negolyte, as it is possible that part of the additive may transfer to the posolyte via the battery membrane.
[0158] In order to attest this compatibility, a test is conducted in a solution containing 0.5 mol / L of potassium ferricyanide and 0.1 mol / L of test compound in order to impose a pH of approximately 13 (in the case where the compound is an acid as in the case of guanidinium-HCl, 0.1 mol / L of KOH is added in order to adjust the pH). A classical electrochemical study is carried out, namely a linear voltammetry from -0.4 V to +0.8 V vs Ag / AgCl at 10 mV / s, using a rotating disc electrode made of glassy carbon with a diameter of 3 mm rotating at 400 RPM. The characteristic half-wave obtained makes it possible to establish the SOC of the electrolyte (the % of ferricyanide present in solution divided by the total quantity of ferricyanide+ferrocyanide present), by calculating the following ratio of the limiting currents: (ii, a ) / (ii, a +ii, c ) ; ii,a = anodic limit current; ii, c = cathodic limit current.
[0159] The SOC measurement of the different solutions is shown in the graph below. After an initial measurement at tO, each solution is stored in an airtight bottle for 7 days. A second SOC test at t + 7 days is then carried out. If the SOC has decreased, this means that part of the ferricyanide has been reduced to ferrocyanide, which indicates oxidation of the solubilizing base.
[0160] The following bases were tested: KOH, LiOH, CsOH, RbOH, guanidine, 1,1,3,3-tetramethyl guanidine, proline, NME4OH, nBu^H, CholineOH, Trimethyl-benzyl ammoniumOH and PBU4OH.
[0161] The experiment shows that all bases do not show any variation in SOC after 7 days, therefore no reduction of ferricyanide to ferrocyanide, except proline and cholineOH. For these two compounds, the SOC after 7 days of contact with a 0.5 mol / L solution of ferricyanide was 77.7% and 82.7%, respectively. It therefore seems that secondary amine bases as well as those with an alkyl chain having a terminal OH are not as compatible with ferricyanide.
[0162] Example 7: Performance of batteries according to the invention and comparison with comparative batteries
[0163] The following two batteries No. 1 and No. 2 were prepared:
[0164] Battery No. 1:
[0165] [Table 6]
[0166] Operating characteristic
[0167] Battery No. 1
[0168] Maximum theoretical capacity = 134 mA.h
[0169] Applied current densities = 40 mA / cm 2 up to cycle 8 then 20 mA / cm 2 Maximum potential difference under load: 1.3 V
[0170] Minimum potential difference during discharge: 0.3 V
[0171] Battery No. 2
[0172] Maximum theoretical capacity: 616 mA.h
[0173] Current densities: 20 mA / cm 2 (charge), 40 mA / cm 2 (dump)
[0174] Maximum potential difference under load = 1.3 V
[0175] Minimum potential difference during discharge = 0.3 V
[0176] Results of battery charge and discharge cycles No. 1 and No. 2
[0177] As shown in Figure 1, the appearance of the electrochemical signature in cyclic voltammetry of the two cationic environments is similar. Similarly, the calculation of the apparent rate constant of electron transfer in the two media results in two very close values.
[0178] In a KOH solution = 0.1 mol.L -1 the rate constant k° = 3.9 x 10~ 3 cm. s 1 In a solution CsOH = 0.1 mol.L -1 the rate constant k° = 3.4 x 10 3 cm. s 1 .
[0179] This analysis highlights that the presence of CsOH as a solubilizing base has little impact on the electrochemical behavior of alizarin, compared to the presence of KOH.
[0180] On the other hand, as shown in Figure 2, the battery capacity drops significantly by around 1% per charge / discharge cycle. This phenomenon, coupled with a low initial capacity, negates the use of alizarin in long-term battery operation under these experimental conditions.
[0181] The drop in capacity can be attributed to two major causes that appear regularly with this type of molecule from the anthraquinone family:
[0182] 1 -) A chemical decomposition of the molecule in its oxidized or reduced form over time.
[0183] 2-) A slow precipitation of the molecule.
[0184] On the contrary, the difference in behavior of alizarin in the presence of CsOH (Figure 3 and 4, compared with Figure 2) is spectacular, because the presence of CsOH allows to solve the two problems mentioned above. In addition to the high capacity obtained thanks to the solubilization effect, it is the very good stability of the charge and discharge cycles obtained beyond 25 cycles which is remarkable. The UV-visible analyses of the oxidized form (at the beginning of charge) and reduced form (at the end of charge) show identical spectra and confirm the chemical stability of alizarin.
[0185] In conclusion, thanks to the addition of CsOH as a solubilizing base, the battery performance is greatly improved.
[0186] Two other batteries No. 3 and No. 4 were also prepared.
[0187] [Table 7]
[0188] Operating characteristic
[0189] Battery No. 3
[0190] Maximum theoretical capacity: 78 mA.h
[0191] Current densities: 40 mA / cm 2 up to cycle no. 120 then 20 mA / cm 2 .
[0192] Maximum potential difference under load = 1.3 V
[0193] Minimum potential difference during discharge = 0.3 V
[0194] Battery No. 4
[0195] Maximum theoretical capacity: 204 mA.h
[0196] Current densities: 20 mA / cm 2 .
[0197] Maximum potential difference under load = 1.3 V
[0198] Minimum potential difference during discharge = 0.3 V Results of charge and discharge cycles for batteries No. 3 and No. 4
[0199] As shown in Figure 5, the capacity of battery No. 3 drops by 0.071% per charge / discharge cycle over the first 100 cycles.
[0200] The capacity loss of battery No. 4, visible in Figure 6, is 0.065% per cycle.
[0201] Comparing the performances of batteries No. 3 and 4 (see figures 5 and 6), we notice, on the one hand, that the accessible capacity of battery 4 is more than 2.5 times greater than that of battery 3 and, on the other hand, that the energy density (see figure 7) has doubled, thanks to the significant increase in the solubility of quinizarin.
[0202] These tests therefore highlight the effectiveness of the solubility exacerbation effect, the main feature of which is a spectacular increase in battery capacity.
[0203] Example 8: Enhancement of the solubility of compounds of formula (I) by the presence of a solubilizing base in combination with a secondary base
[0204] The impact of the presence of a secondary base in the negolyte, in addition to the solubilizing base on the solubility of compounds of formula (I) was evaluated. The solubility of compounds of formula (I) in the presence of Trimethyl benzyl ammonium / KOH, CsOH / KOH or NMe4OH / KOH mixture at different Rc ratios was evaluated. Rc represents the molar ratio between the molar concentration of solubilizing base on the sum of the molar concentration of solubilizing base and the molar concentration of secondary base. The results are presented in the graphs of Figures 8 and 9.
[0205] These results show that the addition of a certain quantity of secondary base makes it possible to significantly increase the conductivity of the negolyte while maintaining a suitable solubility of the compound of formula (I).
Claims
DEMANDS 1. Redox flow battery, comprising: - a first compartment comprising a negolyte, in the form of an aqueous composition, comprising at least one compound of formula (I) and / or a salt of the compound of formula (I), and / or a reduced form of the compound of formula (I), in which X 1 X 2 X 3 X 4 X 5 X 6 X 7 and X 8 are independently chosen from the group consisting of a hydrogen atom, a halogen, an ether group of formula -OA, an OH group, a COOH group, an -A-COOH group, an -OA-COOH group and, a linear, cyclic or branched, saturated or unsaturated hydrocarbon group, comprising from 1 to 10 carbon atoms, A representing a linear, cyclic or branched, saturated or unsaturated hydrocarbon group comprising from 1 to 10 carbon atoms, wherein at least one of X 1X 2 X 3 X 4 X 5 X 6 X 7 and X 8 includes an OH function, a COOH function or an A-COOH group, - a second compartment comprising a posolyte, in the form of an aqueous composition, comprising at least one electroactive molecule, for example ferrocyanide ions [Fe(CN)6] 4 “ and / or ferricyanide ions [Fe(CN)6] 3 “, the negolyte further comprising at least one solubilizing base, the solubilizing base being characterized in that the pKa of the conjugate acid of the solubilizing base is greater than 9.5 in water at 25°C and in that the volume of the cation of the solubilizing base is between 14 and 650 Angstrom cubic.
2. Redox flow battery according to claim 1, characterized in that the solubilizing base is selected from the group consisting of cesium or rubidium hydroxides, cesium or rubidium hydrogen carbonates, cesium or rubidium carbonates, and organic bases having a molar mass between 58 and 400 grams per mole, the organic base not including an OH group in the terminal position.
3. Redox flow battery according to claim 1 or 2, characterized in that the solubilizing base is chosen from the group consisting of: - cesium or rubidium hydroxides, - cesium or rubidium bicarbonates, - cesium or rubidium carbonates, - quaternary phosphonium hydroxides [RI R2R3R4P] + OH _ in which Ri, R2, R3 and R4 are independently chosen from the phenyl group, the phenylalkyls -(CH2) n-Ph with n being an integer from 1 to 5, and alkyl chains in C1-C16, preferably in C1-C6, linear, branched, or cyclic, optionally interrupted by at least one heteroatom chosen from N, O and S, but not including an OH group in terminal position, - quaternary ammonium hydroxides [RsReRyRsNJ+OH; in which either R5, Re, R7 and Rs are independently chosen from the phenyl group, the phenylalkyls -(CH2) n-Ph, where n is an integer from 1 to 5, and C1-C16 alkyl chains, preferably C1-C6, linear, branched, or cyclic, optionally interrupted by at least one heteroatom selected from N, O, and S, but not containing a terminal OH group, or R5 is selected from C4-C20 alkyl chains, preferably C8-C20, advantageously C12-C20, linear, branched, or cyclic, optionally interrupted by at least one heteroatom selected from N, O, and S, but not containing a terminal OH group, and Re, R7, and Rs are independently selected from C1-C3 alkyl chains, linear or branched, optionally interrupted by at least one heteroatom selected from N, O, and S, but not containing a terminal OH group, advantageously Re, R7, and Rs are Methyl groups, namely R5 and Re, are chosen from alkyl chains in C4-C20, preferably in C8-C20, advantageously in C12-C20.linear, branched or cyclic, optionally interrupted by at least one heteroatom chosen from N, O and S, but not including an OH group in terminal position, and R7 and Rs, are independently chosen from C1-C3 alkyl chains, linear or branched, optionally interrupted by, less one heteroatom chosen from N, O, and S, but not containing a terminal OH group, advantageously R? and Rs are methyl groups, i.e., Rs and Re form a saturated alkyl ring comprising 4 to 6 carbon atoms, and R7 and Rs are chosen from linear or branched C1-C6, preferably C1-C3, alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O, and S, but not containing a terminal OH group, advantageously R? and Rs are methyl groups, i.e., R5, Rs, and R? form an aromatic ring comprising 5 carbon atoms, and Rs is chosen from C1-C6 alkyl chains, preferably C1-C3, linear or branched, optionally interrupted by at least one heteroatom chosen from N, O and S, but not comprising an OH group in the terminal position, advantageously Rs is a methyl group, - tertiary amines [R9R10R11N], wherein either R9, R and Ru are independently selected from C1-C8 alkyl chains, preferably C1-C4, advantageously C1-C3, linear, branched or cyclic, optionally interrupted by at least one heteroatom selected from N, O and S, but not comprising a terminal OH group, or Rg and R10 form a saturated alkyl ring comprising 4 to 6 atoms, and Ru is selected from C1-C8 alkyl chains, preferably C1-C4, more preferably C1-C3, linear or branched, optionally interrupted by at least one heteroatom selected from N, O and S, but not comprising a terminal OH group, advantageously Ru is an ethyl or methyl group, - amidines [R a RbNC(Rc)=NR d ] in which R a , Rb, Rc and R d, are independently selected from linear, branched, or cyclic C1-C8, preferably C1-C4, alkyl chains, optionally interrupted by at least one heteroatom selected from N, O, and S, but not including a terminal OH group, i.e., R a and R d form a saturated alkyl ring comprising 2 to 4 carbon atoms, and Rb and R c form a saturated alkyl ring comprising 3 to 5 carbon atoms, each ring possibly being substituted by an alkyl group at C1-C8, preferably at C1-C4, advantageously at C1-C3, linear or branched, - guanidines [R e RfNC(NR g R h )=NH] in which R e , Rf, R g and Rh, are independently selected from C1-C8, preferably C1-C4, linear, branched, or cyclic alkyl chains, optionally interrupted by at least one heteroatom chosen from N, O and S, but not including an OH group in terminal position.
4. A redox flow battery according to any one of the preceding claims, characterized in that the solubilizing base is selected from the group consisting of CsOH, RbOH, trimethylamine, triethylamine, ethyldimethylamine, methyldiethylamine, N-methylpyrrolidine, N-ethylpyrrolidine, N-methylpiperidine, N-ethylpiperidine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,1,3,3-tetramethylguanidine, tetramethylammonium hydroxide, tetraethylammonium hydroxide, tetrapropylammonium hydroxide, tetrabutylammonium hydroxide, trimethylbenzylammonium hydroxide, trimethylcetylammonium hydroxide, dimethyldidocecylammonium hydroxide, trimethylphenylammonium hydroxide, N-methylpyridinium hydroxide, N,N-dimethylpyrrolidinium hydroxide, N,N-dimethylpiperidinium hydroxide and tetrabutylphosphonium hydroxide.
5. A redox flow battery according to any one of the preceding claims, characterized in that the solubilizing base is selected from the group consisting of CsOH, RbOH, trimethylamine, triethylamine, N-methylpyrrolidine, 1,1,3,3-tetramethylguanidine, tetramethylammonium hydroxide, tetrabutylammonium hydroxide, trimethylbenzylammonium hydroxide, and tetrabutylphosphonium hydroxide.
6. A redox flow battery according to any one of the preceding claims, characterized in that the solubilizing base has a molar concentration in the negolyte of between 0.1 mol / L and 5.0 mol / L, preferably between 0.2 mol / L and 4.0 mol / L, preferably between 0.3 mol / L and 3.0 mol / L, advantageously between 0.4 mol / L and 2.5 mol / L 7. Redox flow battery according to any one of the preceding claims, characterized in that the negolyte further comprises a secondary base selected from potassium hydroxide, sodium hydroxide, lithium hydroxide, ammonium hydroxide, preferably from potassium hydroxide, sodium hydroxide and lithium hydroxide.
8. Redox flow battery according to claim 7, characterized in that the secondary base has a molar concentration in the negolyte of between 0.01 mol / L and 5.0 mol / L, preferably between 0.2 mol / L and 4.0 mol / L, preferably between 0.3 mol / L and 3.0 mol / L, advantageously between 0.4 mol / L and 2.5 mol / L.
9. Redox flow battery according to claim 7 or 8, characterized in that, in the negolyte, the ratio between [M SOiU b,nego] and [M' Se[Msoiub.nego] is greater than or equal to 0.1, preferably greater than or equal to 0.3, more preferably greater than or equal to 0.6 and less than or equal to 10, advantageously greater than or equal to 0.8 and less than or equal to 3, [Msoiub.nego] corresponding to the molar concentration in the negolyte of the solubilizing base cation and [M' Se cond,nego] corresponding to the molar concentration in the negolyte of the cation of the secondary base.
10. Redox flow battery according to any one of the preceding claims, characterized in that the posolyte comprises at least one base selected from the solubilizing bases as defined in any one of claims 1 to 5 and the secondary bases as defined in claim 7.
11. Redox flow battery according to claim 10, characterized in that the base has a molar concentration in the posolyte of between 0.01 mol / L and 1.00 mol / L preferably between 0.01 mol / L and 0.60 mol / L, preferably between 0.01 mol / L and 0.40 mol / L, advantageously between 0.01 mol / L and 0.20 mol / L.
12. Redox flow battery according to any one of the preceding claims, characterized in that X 1 X 2 X 3 X 4 X 5 X 6 X 7 and X 8 of the compound of formula (I) are independently chosen from the group consisting of a hydrogen atom, an OH group, a COOH group, a (CH2) group n -COOH where n is an integer ranging from 1 to 10 and a linear, cyclic or branched, saturated or unsaturated hydrocarbon group, comprising from 1 to 10 carbon atoms.
13. Redox flow battery according to any one of the preceding claims, characterized in that the negolyte and / or the posolyte is / are free of Cl' ion and Br ion, preferably is / are free of halide ion, the halide ion being chosen from F, Ch, Br and h.
14. A redox flow battery according to any one of claims 1 to 13, characterized in that it further comprises a membrane, preferably a membrane amphoteric or a semi-permeable cation exchange membrane, said membrane comprising a material selected from the group consisting of fluorinated (co)polymers, (co)poly(ether ketone), (co)poly(ether sulfone), (co)poly(ether-ether-ketone), sulfonated (co)poly(ether-ether-ketone), benzimidazole (co)polymers and arylene-based (co)polymers, preferably selected from the group consisting of sulfonated tetrafluoroethylene-based fluorinated copolymers, perfluorosulfonic acid ionomers, and sulfonated (co)poly(ether-ether-ketone).
15. Method of producing electricity by at least one redox flow battery, characterized in that the redox flow battery is defined according to any one of claims 1 to 14.
